<?xml version="1.0" encoding="UTF-8"?><measure><measureDetails><uuid>40280381-4de7-db4d-014d-e9482dd402ed</uuid><title>Preventive Care and Screening: Risk-Stratified Cholesterol -Fasting Low Density Lipoprotein (LDL-C)</title><shortTitle>CMS64</shortTitle><emeasureid>64</emeasureid><guid>0336a17b-7c2a-48fc-a657-e9b04269a4cc</guid><version>5.1.000</version><nqfid extension="Not Applicable" root="2.16.840.1.113883.3.560.1"/><period calenderYear="true" uuid="40280381-3e93-d1af-013e-b297a0bb5bc3"><startDate>00000101</startDate><stopDate>00001231</stopDate></period><steward id="9048cd4c-b61b-11e4-a71e-12e3f512a338">Centers for Medicare &amp; Medicaid Services (CMS)</steward><developers><developer id="2.16.840.1.113883.3.600.0001">Quality Insights of Pennsylvania</developer></developers><description>Percentage of patients aged 20 through 79 years who had a fasting LDL-C test performed and whose risk-stratified fasting LDL-C is at or below the recommended LDL-C goal.</description><copyright>Limited proprietary coding is contained in the measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. Quality Insights of Pennsylvania disclaims all liability for use or accuracy of any Current Procedural Terminology (CPT [R]) or other coding contained in the specifications.&#xD;
&#xD;
CPT (R) contained in the Measure specifications is copyright 2007- 2015 American Medical Association. &#xD;
&#xD;
LOINC (R) copyright 2004-2014 [2.50] Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms (R) (SNOMED CT [R]) copyright 2004-2014 [2014-09] International Health Terminology Standards Development Organization. All Rights Reserved.&#xD;
&#xD;
Due to technical limitations, registered trademarks are indicated by (R) or [R] and unregistered trademarks are indicated by (TM) or [TM].</copyright><disclaimer>These performance measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications.&#xD;
&#xD;
THE MEASURES AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND.</disclaimer><scoring id="PROPOR">Proportion</scoring><types><type id="PROCESS">Process</type></types><componentMeasures/><itemCount/><stratification>There are three criteria for this measure based on the patient's risk category. When a patient could be included in multiple risk categories, the "higher" level of risk will be utilized.&#xD;
1. Highest Level of Risk: Coronary Heart Disease (CHD) or CHD Risk Equivalent OR 10 year Framingham risk &gt; 20%&#xD;
&#xD;
2. Moderate Level of Risk: Multiple (2+) Risk Factors OR 10 year Framingham risk 10-20%&#xD;
&#xD;
3. Lowest Level of Risk: 0 or 1 Risk Factor OR 10 year Framingham risk &lt; 10%</stratification><riskAdjustment>None</riskAdjustment><aggregation>This measure will be calculated for each of the three strata based on risk category for all patients aged 20 through 79 years who were seen by the eligible professional during the measurement period.</aggregation><rationale>The Agency for Healthcare Research and Quality (AHRQ) conducts systematic evidence reviews prior to recommendations issued by the U.S. Preventive Services Task Force (USPSTF). In the systematic evidence review, "Screening for Lipid Disorders" by, (Pignone MP et al.  2001), "Coronary Heart Disease (CHD) was identified as the leading cause of morbidity and mortality in the United States, causing nearly 500,000 deaths each year and requiring nearly 12 million hospital days of care per year. It is the leading cause of disabled life-years and is second only to injuries as a cause of life-years lost. The age -adjusted annual death rate for CHD is 100 per 100,000 persons overall and 140 per 100,000 persons among African Americans. The lifetime risk of having a CHD event, calculated at age 40, is estimated to be 49% for men and 32% for women in the United States. CHD accounted for $78 billion in health care costs in 1995" (Pignone MP, et. al. 2001, p. 1).&#xD;
&#xD;
In June 2008, Helfand &amp; Carson (2008) provided a paper called "Screening for Lipid Disorders in Adults: Selective Update of 2001; U.S. Preventive Services Task Force Review" to renew Pignone's (2001) earlier evidence. Helfand &amp; Carson  (2008) stated: "Based on the National Health and Examination Survey (NHANES) III data in the general US  population, 8.9% of men aged 18-35 and 12.3% of women aged 18-45 have a Total Cholesterol( TC) &gt;240 mg/dL.  Among men aged 18-35 and women younger than 40 who do not smoke, do not have a history of hypertension, and do not have diabetes mellitus, no combination of ATP-III risk factors (TC up to 310 mg/dL and systolic blood pressure) would result in a predicted 10-year risk of major cardiovascular events greater than 10%. Some men younger than 35 years of age who smoke and those who have diabetes have a 10-year risk that exceeds 10% but these men can be identified for lipid testing based on their history. In NHANES, among all non-diabetic women aged 40-45 years, the  probability of being at intermediate or high risk were 1.45% and 0%, respectively; all of these women had a history of hypertension or smoking" (Helfand M &amp; Carson S, 2008, p. 5).&#xD;
&#xD;
The risk of CHD is independently related to several potentially modifiable risk factors besides abnormal lipids, including smoking, diabetes, hypertension, and physical inactivity. Recent epidemiologic studies and basic science research expanded knowledge about several new potential CHD risk factors. Use of a Framingham risk-based algorithm that directly incorporates age, the presence and magnitude of other risk factors, and measures of total cholesterol and HDL is the most accurate approach. "Screening for lipid disorders by measuring cholesterol levels in adult patients is quite feasible for physicians because it involves ordering only a blood test.&#xD;
&#xD;
Providers appear to have achieved high levels of lipid screening based on population-based patient survey data." (Pignone MP, et. al., 2001, p. 34).AHRQ, 2001) This systematic review recommends using a supplemental table to improve the feasibility of a risk-based strategy. In the Helfand &amp; Carson (2008) update to Pignone's "Screening for  Lipid Disorders"  (Pignone MP, 2001), the researchers state: "We did not identify new evidence relevant to the&#xD;
appropriate interval to screen for hyperlipidemia in the general population or in subgroups of the general population" (Helfand M &amp; Carson S, 2008, p. 5).&#xD;
&#xD;
The primary recommendation of several advisory groups bodies state that adults should undergo an office-based assessment as the first step to identify patients at a higher CHD risk. The National Cholesterol Education Program Panel III (NCEP- III) has adopted using an adaptation of the risk prediction algorithm originating from the Framingham Heart Study estimating a patient's 10-year risk for developing CHD and has recommended its' use as the primary goal of preventive treatment. Stratifying CHD risk includes determining if CHD is present as well as CHD risk equivalents and major CHD risk factors. A history of CHD includes myocardial infarction, myocardial ischemia, angina (stable, unstable), percutaneous transluminal coronary angioplasty &amp; coronary artery bypass surgery. CHD risk equivalents include peripheral artery disease, abdominal aortic aneurysm, thrombotic stroke, transient ischemic attacks, diabetes &amp; Framingham 10-yr CHD risk &gt; 20%. Major CHD risk factors include age, yr (men &gt;45; women &gt;55), cigarette smoking, hypertension (BP &gt;140/90 mm Hg) or anti- hypertensive medication, Low HDL-C (&lt;40 mg/dL) &amp; negative risk factor: high HDL-C (&gt;60 mg/dL). The Framingham risk categories include sex, age, systolic blood pressure, smoking status, total cholesterol, and HDL-C levels (NCEP III, 2002).&#xD;
&#xD;
Nelson RH (2013) noted that "regardless of the recommendations it is useful to consider how successful the medical community has been in meeting guideline goals...a national survey...showed 67% of ...patients with elevated cholesterol achieved their LDL cholesterol treatment goal". Nelson (2013) also stated "data from the National Health and Nutrition Examination Survey (NHANES) documents a steady decline in total cholesterol over several decades, so that in 2002 no more than 17% of US adults had a total cholesterol level of 240 mg/dL or higher. More recent data from an identical survey in 2008 show that the Healthy People 2010 goal of an average cholesterol below 200 mg/dL in all adults ages 20 to 74 was met by both men and women by 2008" (Nelson RH, 2013, p. 202).&#xD;
&#xD;
"Based on data from the 2005-2008 NHANES, an estimated 71 million (35.5%) U.S. adults aged&gt;=20 years had high LDL-C, but only 34 million (48.1%) were treated and 23 million (32.2%) had their LDL-C controlled....The prevalence of LDL-C control was lowest among persons who reported receiving medical care less than twice in the previous year (11.7%, being uninsured (13.5%), being Mexican American (20.3%) or having income below the poverty level (21.9%)" (Kuklina EV, et. al., 2011, p. 109).</rationale><recommendations>Routine cholesterol testing should begin in young adulthood (&gt;= 20 years of age). When LDL cholesterol concentrations range from 100-129 mg/dL, young adults should be encouraged to modify life habits to minimize long-term risk. In those with borderline high LDL cholesterol (130-159 mg/dL), clinical attention through therapeutic lifestyle changes is needed both to lower LDL cholesterol and to minimize other risk factors. If LDL cholesterol is high (160-189 mg/dL), more intensive clinical intervention should be initiated, with emphasis on therapeutic lifestyle changes.&#xD;
&#xD;
However, if LDL cholesterol remains elevated despite therapeutic lifestyle changes, particularly when LDL cholesterol is &gt;= 190 mg/dL, consideration should be given to long-term management with LDL-lowering drugs.&#xD;
&#xD;
ATP III recognizes that detection of cholesterol disorders and other coronary heart disease (CHD) risk factors occurs primarily through clinical case finding. Risk factors can be detected and evaluated as part of a person's work-up for any medical problem. Alternatively, public screening programs can identify risk factors, provided that affected individuals are appropriately referred for physician attention. The identification of cholesterol disorders in the setting of a medical examination has the advantage that other cardiovascular risk factors-including prior CHD, PVD, stroke, age, sex, family history, cigarette smoking, high blood pressure, diabetes mellitus, obesity, physical inactivity- co-morbidities, and other factors can be assessed and considered prior to treatment.&#xD;
&#xD;
National Cholesterol Education Program, &#xD;
National Heart, Lung, and Blood Institute,&#xD;
National Institutes of Health,&#xD;
 NIH Publication No. 02-5215, &#xD;
September 2002&#xD;
&#xD;
Wilkinson J (2012) states that screening "must be recommended for men over age 34 and women over age 44 every five years in the "Preventative Services for Adults, Institute for Clinical Systems Improvement (ICSI) Guideline (Wilkinson J, et. al. 2012, p.20).  Varbo (2013) also agreed that "LDL cholesterol is well documented as a causal risk factor for ischemic heart  disease" (Varbo A, et. al., 2013, p. 435).&#xD;
&#xD;
The U.S. Preventive Services Task Force (USPSTF),  2008 strongly recommends screening men aged 35 and older for lipid disorders (Helfand M &amp; Carson S, 2008, p. 40).&#xD;
&#xD;
The USPSTF recommends screening men aged 20 to 35 for lipid disorders if they are at increased risk for coronary heart disease (Helfand M &amp; Carson S, 2008).&#xD;
&#xD;
The USPSTF strongly recommends screening women aged 45 and older for lipid disorders if they are at increased risk for coronary heart disease (Helfand M &amp; Carson S, 2008).&#xD;
&#xD;
The USPSTF recommends screening women aged 20 to 45 for lipid disorders if they are at increased risk for coronary heart disease (Helfand M &amp; Carson S, 2008).&#xD;
&#xD;
The USPSTF makes no recommendation for or against routine screening for lipid disorders in men aged 20 to 35, or in women aged 20 and older who are not at increased risk for coronary heart disease (Helfand M &amp; Carson S, 2008).&#xD;
&#xD;
Nelson (2013) agrees that the recommendations of the USPSTF, published in 2008, remain current and viable in 2013 (Nelson RH, 2013). &#xD;
The National Strategy for Quality Improvement in Health Care for 2011 has identified the promotion of the most effective prevention and treatment practices for the leading causes of mortality, starting with cardiovascular disease as one of its' national priorities. These priorities are based on the most recent research as well as stakeholder input. Opportunities for success include increase blood pressure control in adults, reduced high cholesterol levels in adults, and decrease smoking among adults and adolescents. Illustrative measures include:&#xD;
* Percentage of patients ages 18 years and older with ischemic vascular disease whose most recent blood pressure during the measurement year is &lt;140/90 mm Hg&#xD;
* Percentage of patients with ischemic vascular disease whose most recent low-density cholesterol is &lt;100&#xD;
* Percentage of patients who received evidence-based smoking cessation services (eg, medications)&#xD;
&#xD;
The U.S. Department of Health and Human Service's Healthy People 2020 has set a target of 82.1% for HDS-6: Increase the proportion of adults who have had their blood cholesterol checked within the preceding 5 years (a 10% improvement over the next decade).</recommendations><improvementNotations>Higher score indicates better quality.</improvementNotations><references><reference>Helfand M, Carson S (2008). Screening for lipid disorders in adults: selective update of 2001 U.S. Preventive Services Task Force Review. Evidence Synthesis No. 49. Rockville, MD: Agency for Healthcare Research and Quality. AHRQ Publication no. 08-05114-EF-1. Retrieved from http://www.ahrq.gov/downloads/pub/prevent/pdfser/lipides.pdf.</reference><reference>U. S. Department of Health and Human Services, (2002). Third Report of the National Cholesterol Educational Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III) Final Report, NIH Publication No. 02-5215</reference><reference>Agency for Healthcare Research and Quality (AHRQ) (2012). The Guide to Clinical Preventive Services 2012:  Recommendations of the U.S. Preventive Services Task Force (USPSTF) U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality. AHRQ Pub. No.12-05154:  ISBN 978-58763-421-5.</reference><reference>Kuklina EV, Shaw M, Hong Y (2011). Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion (CDC). Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol; United States, 1999-2002 and 2005-2008. Morbidity and Mortality Weekly Report (MMWR), 60(4), February 4, 2011; 109-114.</reference><reference>Nelson RH (2013). Hyperlipidemia as a Risk Factor for Cardiovascular Disease. Prim Care Clin Office Pract 40:195-211. </reference><reference>Wilkinson J, Bass C, Diem S, Gravley A, Harvey L, Hayes R, Johnson K, Maciosek M, McKeon K, Milteer L, Morgan J, Rothe P, Snellman L, Solberg L, Storlie C, Vincent P (2012).  Institute for Clinical Systems Improvement. &#xD;
Preventive Services for Adults Updated September 2012. Retrieved: http://bit.ly.PrevServAdults091&#xD;
</reference><reference>Varbo A, Benn M, Tybjaerg-Hansen A, Jorgensen AB, Frikke-Schmidt R, Nordestgaard BG (2013). Remnant cholesterol as a causal risk factor for ischemic heart disease. Journal of the American College of Cardiology, 61(4):427-436.</reference><reference>Health &amp; Human Services. (2011). The National Strategy for Quality Improvement in Health Care for 2011</reference><reference>Pignone MP, Phillips CJ, Lannon CM, Mulrow CD, Teutsch SM, Lohr KN, Whitener BL (2001). Screening for lipid disorders. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ) (Systematic evidence review; no. 4).  Retrieved from http://guideline.gov/content.aspx?id=12634&amp;search=screening+for+lipid+disorders+in+adults</reference></references><definitions>CHD:&#xD;
History of CHD includes:&#xD;
* Myocardial Infarction&#xD;
* Myocardial Ischemia&#xD;
* Angina (stable, unstable)&#xD;
* Percutaneous Transluminal Coronary Angioplasty&#xD;
* Coronary Artery Bypass Surgery&#xD;
&#xD;
CHD Risk Equivalent:&#xD;
A CHD risk equivalent is a condition that carries an absolute risk for developing new CHD equal to the risk for having recurrent CHD events in persons with established CHD including:&#xD;
* Atherosclerotic disease&#xD;
* Peripheral arterial disease (PAD)&#xD;
* Carotid artery disease&#xD;
* Abdominal aortic aneurysm (AAA)&#xD;
* Stroke&#xD;
* Diabetes &#xD;
   o Type 1 &#xD;
   o Type 2&#xD;
* Framingham 10-yr CHD risk &gt; 20%&#xD;
&#xD;
Major CHD Risk Factors:&#xD;
* Cigarette smoking&#xD;
* Active diagnosis of hypertension or on antihypertensive medication&#xD;
* Low HDL cholesterol (HDL-C) (&lt;40 mg/dL)&#xD;
* Family history of premature CHD&#xD;
* CHD in male first-degree relative &lt;55 years&#xD;
OR&#xD;
* CHD in female first-degree relative &lt;65 years&#xD;
* Age (men &gt;=45 years; women &gt;=55 years)&#xD;
&#xD;
Most Recent LDL-C Test:&#xD;
A LDL-C test performed or LDL-C result verified by another provider.&#xD;
&#xD;
10-year Framingham risk: &#xD;
The Framingham Risk Score will be calculated based on the patient data below and will follow the Adult Treatment Panel (ATP) III Guidelines. (see appendix for calculation unless automatically calculated by EHR)&#xD;
* Sex&#xD;
* Age&#xD;
* Total cholesterol - Fasting&#xD;
* HDL cholesterol - Fasting&#xD;
* Systolic blood pressure (treated or untreated)&#xD;
* Smoking status (Cigarette smoking)&#xD;
&#xD;
Calculated LDL-C* results:&#xD;
Are acceptable if the other elements (TRIGLYCERIDES, TOTAL CHOLESTEROL, and HIGH DENSITY LIPOPROTEIN (HDL-C) listed below are submitted AND the triglyceride value is &lt;= 400 mg/dL.&#xD;
* Calculated LDL value = [TOTAL CHOLESTEROL value - HIGH DENSITY LIPOPROTEIN (HDL-C) value - (TRIGLYCERIDE value/5)]&#xD;
Risk Level Recommended LDL-C Goal:&#xD;
CHD and CHD Risk Equivalent: &lt;100 mg/dL &#xD;
Multiple (2+) Risk Factors:  &lt;130 mg/dL&#xD;
0-1 Risk Factor :  &lt;160 mg/dL&#xD;
* LDL-C goal for multiple-risk-factor persons with 10-year risk &gt;20 percent = &lt;100 mg/dL</definitions><guidance>This is a two -part measure which is paired with CMS 61: Preventive Care and Screening: Cholesterol - Fasting Low Density Lipoprotein (LDL-C) Test Performed. If the fasting LDL-C results are documented this measure CMS 64 should also be reported.&#xD;
&#xD;
To be eligible for performance calculations, patients must have at least one face-to -face visit with the eligible professional during the measurement period and have one fasting LDL-C performed during the same measurement period with the exception of patients with 0 or 1 risk factors who may have an fasting LDL-C performed up to four (4) years prior to the current measurement period.  To meet the numerator criteria for this measure, the patient's fasting LDL-C (low density lipoprotein) meets or exceeds the recommended LDL-C goal.</guidance><transmissionFormat>TBD</transmissionFormat><initialPopDescription>All patients 20 through 79 years of age before the beginning of the measurement period</initialPopDescription><denominatorDescription>Denominator 1: (High Risk)&#xD;
All patients aged 20 through 79 years who had a fasting LDL-C or a calculated LDL-C test performed during the measurement period and have CHD or CHD Risk Equivalent OR 10 year Framingham risk &gt; 20%&#xD;
&#xD;
Denominator 2: (Moderate Risk)&#xD;
All patients aged 20 through 79 years who had a fasting LDL-C or a calculated LDL-C test performed during the measurement period and have 2 or more Major CHD Risk Factors OR 10 year Framingham Risk 10-20%.  &#xD;
&#xD;
Denominator 3: (Low Risk)&#xD;
All patients aged 20 through 79 years who had a fasting LDL-C or a calculated LDL-C test performed up to 4 years prior to the current measurement period and have 0 or 1 Major CHD Risk Factors OR 10 year Framingham risk &lt;10%.  &#xD;
&#xD;
** For Denominator 2 and Denominator 3, HDL-C &gt; or equal to 60 mg/dL subtracts 1 risk from the above (This is a negative risk factor.)</denominatorDescription><denominatorExclusionsDescription>Patients who have an active diagnosis of pregnancy&#xD;
OR&#xD;
Patients who are receiving palliative care</denominatorExclusionsDescription><numeratorDescription>Numerator 1:&#xD;
Patients whose most recent fasting LDL-C test result is in good control, defined as &lt;100 mg/dL&#xD;
Numerator 2:&#xD;
Patients whose most recent fasting LDL-C test result is in good control, defined as &lt;130 mg/dL&#xD;
Numerator 3:&#xD;
Patients whose most recent fasting LDL-C test result is in good control, defined as &lt;160 mg/dL</numeratorDescription><numeratorExclusionsDescription>Not Applicable</numeratorExclusionsDescription><denominatorExceptionsDescription>None</denominatorExceptionsDescription><measurePopulationDescription>Not Applicable</measurePopulationDescription><measurePopulationExclusionsDescription>Not Applicable</measurePopulationExclusionsDescription><measureObservationsDescription>Not Applicable</measureObservationsDescription><supplementalData>For every patient evaluated by this measure also identify payer, race, ethnicity and sex.</supplementalData><qualityMeasureSet uuid="5e312bf8-bc40-4e54-8f7a-554c5fd4cc6d">Preventive Care and Screening</qualityMeasureSet>
<finalizedDate value="201506121559-0500"/>
</measureDetails><supplementalDataElements><elementRef id="40280381-3e93-d1af-013e-b297a0bb5bbc" name="ONC Administrative Sex"/><elementRef id="40280381-3e93-d1af-013e-b297a0bb5bbd" name="Race"/><elementRef id="40280381-3e93-d1af-013e-b297a0bb5bbe" name="Ethnicity"/><elementRef id="40280381-3e93-d1af-013e-b297a0bb5bbf" name="Payer"/></supplementalDataElements><riskAdjustmentVariables/><subTreeLookUp><subTree displayName="Age greater than or equal to 20 years at MP" qdmVariable="false" uuid="54385F6D-6CE1-4F22-93EE-E4E9DA49BAE7"><functionalOp displayName="Age &gt;= 20 years at" operatorType="Greater Than or Equal To" quantity="20" type="AGE AT" unit="years"><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></functionalOp></subTree><subTree displayName="Age less than 79 years at MP" qdmVariable="false" uuid="001EB302-CDD4-4356-B358-A1C511E17A00"><functionalOp displayName="Age &lt; 79 years at" operatorType="Less Than" quantity="79" type="AGE AT" unit="years"><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></functionalOp></subTree><subTree displayName="Enc Perf Cholesterol Measure Encounter Codes during MP" qdmVariable="false" uuid="BB766D21-AC99-4E25-A2C1-F5F085BE1312"><relationalOp displayName="During" type="DURING"><elementRef displayName="Cholesterol Measure Encounter Codes : Encounter, Performed" id="40280381-3e93-d1af-013e-b297a0bd5bdf" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></subTree><subTree displayName="Lab Test Perf LDL Code during MP" qdmVariable="false" uuid="26AA211E-9029-4A14-9C32-E0A46836FD74"><relationalOp displayName="During" type="DURING"><elementRef displayName="LDL Code : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bb5bba" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></subTree><subTree displayName="Lab Test Perf Total Cholesterol during MP" qdmVariable="false" uuid="7FD31CD6-86B2-44C6-A912-9CC8E72CD376"><relationalOp displayName="During" type="DURING"><elementRef displayName="Total Cholesterol : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bb5bc6" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></subTree><subTree displayName="Lab Test Perf HDL during MP" qdmVariable="false" uuid="D65C20DE-E60A-4A83-ADC1-ABE0230F62A6"><relationalOp displayName="During" type="DURING"><elementRef displayName="High Density Lipoprotein (HDL) : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bc5bc7" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></subTree><subTree displayName="Lab Test Perf Triglycerides during MP" qdmVariable="false" uuid="0522A896-80D2-4CF5-9F12-A2DFC5AE324A"><relationalOp displayName="During" type="DURING"><elementRef displayName="Triglycerides : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bc5bc8" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></subTree><subTree displayName="RCA Framingham result greater than 20 during MP" qdmVariable="false" uuid="C5FC1EDC-627A-4D0C-97D6-550EFE31C351"><relationalOp displayName="During" type="DURING"><elementRef displayName="Framingham coronary heart disease 10 year risk : Risk Category Assessment" id="40280381-3e93-d1af-013e-b297a0bc5bd1" type="qdm"><attribute attrUUID="44f6922b-64f6-497f-a2a2-06cc2a2996e4" comparisonValue="20" mode="Greater Than" name="result" unit="%"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></subTree><subTree displayName="Lab Test Perf LDL Code sat all Most Recent result during MP less than 100" qdmVariable="false" uuid="9BABA815-7F07-445E-8E7C-4DBE4E4E0839"><functionalOp displayName="SATISFIES ALL" type="SATISFIES ALL"><elementRef displayName="LDL Code : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bb5bba" type="qdm"/><relationalOp displayName="During" type="DURING"><functionalOp displayName="MOST RECENT" type="MOST RECENT"><elementRef displayName="LDL Code : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bb5bba" type="qdm"><attribute attrUUID="b9e07da1-dc60-41c7-8e1c-b1a98e9b52a4" mode="Check if Present" name="result"/></elementRef></functionalOp><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp><elementRef displayName="LDL Code : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bb5bba" type="qdm"><attribute attrUUID="a6363b70-8895-4811-b22f-9bed7cb8d237" comparisonValue="100" mode="Less Than" name="result" unit="mg/dL"/></elementRef></functionalOp></subTree><subTree displayName="RCA Framingham result greater than equal to 10 during MP" qdmVariable="false" uuid="D4DFB31C-92D8-47AA-B0EA-433614B01DC6"><relationalOp displayName="During" type="DURING"><elementRef displayName="Framingham coronary heart disease 10 year risk : Risk Category Assessment" id="40280381-3e93-d1af-013e-b297a0bc5bd1" type="qdm"><attribute attrUUID="9ecae8c0-a853-4adb-81c5-d745bcec2592" comparisonValue="10" mode="Greater Than Or Equal To" name="result" unit="%"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></subTree><subTree displayName="FraminghamCADRiskFactors" qdmVariable="true" uuid="48DDF399-6821-4759-A46C-1B9BC89B6B81"><setOp displayName="UNION" type="union"><functionalOp displayName="FIRST" type="FIRST"><relationalOp displayName="Starts Before End Of" type="SBE"><elementRef displayName="Current Tobacco Smoker : Patient Characteristic" id="40280381-3e93-d1af-013e-b297a0bb5bb6" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></functionalOp><functionalOp displayName="FIRST" type="FIRST"><relationalOp displayName="Starts Before End Of" type="SBE"><elementRef displayName="Family History CHD : Diagnosis, Family History" id="40280381-3e93-d1af-013e-b297a0bc5bce" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></functionalOp><functionalOp displayName="FIRST" type="FIRST"><relationalOp displayName="During" type="DURING"><elementRef displayName="High Density Lipoprotein (HDL) : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bc5bc7" type="qdm"><attribute attrUUID="28ad4c28-75a5-4a88-a0ae-970a9145e864" comparisonValue="40" mode="Less Than" name="result" unit="mg/dL"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></functionalOp><functionalOp displayName="FIRST" type="FIRST"><setOp displayName="UNION" type="union"><relationalOp displayName="Starts Before End Of" type="SBE"><elementRef displayName="Diagnosis of hypertension  : Diagnosis, Active" id="40280381-3e93-d1af-013e-b297a0bc5bcf" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp><relationalOp displayName="During" type="DURING"><elementRef displayName="Anti-Hypertensive Pharmacologic Therapy : Medication, Active" id="40280381-3e93-d1af-013e-b297a0bc5bd8" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></setOp></functionalOp></setOp></subTree><subTree displayName="Count greater than equal to 3 of FraminghamCADRiskFactor" qdmVariable="false" uuid="B7F7DAFA-23BC-4A06-83FF-BC5FA4D0FE4A"><functionalOp displayName="COUNT &gt;= 3 " operatorType="Greater Than or Equal To" quantity="3" type="COUNT"><subTreeRef displayName="FraminghamCADRiskFactors" id="48DDF399-6821-4759-A46C-1B9BC89B6B81" type="subTree"/></functionalOp></subTree><subTree displayName="Patient Characteristic Sex Male" qdmVariable="false" uuid="269A842B-9ECE-4B77-A746-8064D5647515"><elementRef displayName="Male : Patient Characteristic Sex" id="40280381-3e93-d1af-013e-b297a0bd5be8" type="qdm"/></subTree><subTree displayName="Age greater than or equal to 45 years at MP" qdmVariable="false" uuid="11CE2948-A957-4027-BCA0-B934B2E43062"><functionalOp displayName="Age &gt;= 45 years at" operatorType="Greater Than or Equal To" quantity="45" type="AGE AT" unit="years"><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></functionalOp></subTree><subTree displayName="Patient Characteristic Sex Female" qdmVariable="false" uuid="6AB9E19A-F545-43F1-B9E0-54F6E718F201"><elementRef displayName="Female : Patient Characteristic Sex" id="40280381-3e93-d1af-013e-b297a0bd5be7" type="qdm"/></subTree><subTree displayName="Age greater than or equal to 55 years at MP" qdmVariable="false" uuid="00D2035B-1BCE-4428-BFDE-06CA2220D93F"><functionalOp displayName="Age &gt;= 55 years at" operatorType="Greater Than or Equal To" quantity="55" type="AGE AT" unit="years"><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></functionalOp></subTree><subTree displayName="RecentLowHDLResult" qdmVariable="true" uuid="9C8B66CF-FD45-46BA-BA34-FF2F3CB85B77"><functionalOp displayName="SATISFIES ALL" type="SATISFIES ALL"><elementRef displayName="High Density Lipoprotein (HDL) : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bc5bc7" type="qdm"/><functionalOp displayName="MOST RECENT" type="MOST RECENT"><relationalOp displayName="During" type="DURING"><elementRef displayName="High Density Lipoprotein (HDL) : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bc5bc7" type="qdm"><attribute attrUUID="37030917-174a-4044-a6be-af9c9aa41f4b" mode="Check if Present" name="result"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></functionalOp><elementRef displayName="High Density Lipoprotein (HDL) : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bc5bc7" type="qdm"><attribute attrUUID="054c9272-f52f-4972-ba31-65d35e593cf3" comparisonValue="60" mode="Less Than" name="result" unit="mg/dL"/></elementRef></functionalOp></subTree><subTree displayName="Count equals 2 of FraminghamCADRiskFactors" qdmVariable="false" uuid="357F3F24-9D2A-4467-8D49-674E78FA87CC"><functionalOp displayName="COUNT = 2 " operatorType="Equal To" quantity="2" type="COUNT"><subTreeRef displayName="FraminghamCADRiskFactors" id="48DDF399-6821-4759-A46C-1B9BC89B6B81" type="subTree"/></functionalOp></subTree><subTree displayName="Lab Test Perf LDL Code sat all Most Recent result during MP less than 130" qdmVariable="false" uuid="2558E5BD-A977-43FF-A106-2B3F30C45CBC"><functionalOp displayName="SATISFIES ALL" type="SATISFIES ALL"><elementRef displayName="LDL Code : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bb5bba" type="qdm"/><functionalOp displayName="MOST RECENT" type="MOST RECENT"><relationalOp displayName="During" type="DURING"><elementRef displayName="LDL Code : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bb5bba" type="qdm"><attribute attrUUID="8b3cebd0-a904-4862-9548-5db5f54e0633" mode="Check if Present" name="result"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></functionalOp><elementRef displayName="LDL Code : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bb5bba" type="qdm"><attribute attrUUID="a1d68ccb-081f-41e2-9e89-412cc27b743b" comparisonValue="130" mode="Less Than" name="result" unit="mg/dL"/></elementRef></functionalOp></subTree><subTree displayName="Lab Test Perf LDL Code less than equal to 4 years SBS MP" qdmVariable="false" uuid="E0807EEB-063D-4CC9-A4C2-792318E60CBF"><relationalOp displayName="&lt;= 4 years Starts Before Start Of" operatorType="Less Than or Equal To" quantity="4" type="SBS" unit="years"><elementRef displayName="LDL Code : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bb5bba" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></subTree><subTree displayName="Lab Test Perf Total Cholesterol less than or equal to 4 years SBS MP" qdmVariable="false" uuid="E6057D37-E12B-4C23-A121-E8889FBCDBA4"><relationalOp displayName="&lt;= 4 years Starts Before Start Of" operatorType="Less Than or Equal To" quantity="4" type="SBS" unit="years"><elementRef displayName="Total Cholesterol : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bb5bc6" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></subTree><subTree displayName="Lab Test Perf HDL less than or equal to 4 years SBS MP" qdmVariable="false" uuid="AF55C607-47BA-4A86-A13C-9F87B23DF3A2"><relationalOp displayName="&lt;= 4 years Starts Before Start Of" operatorType="Less Than or Equal To" quantity="4" type="SBS" unit="years"><elementRef displayName="High Density Lipoprotein (HDL) : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bc5bc7" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></subTree><subTree displayName="Lab Test Perf Triglycerides less than or equal to 4 years SBS MP" qdmVariable="false" uuid="90BD9BC5-F79D-47BB-9183-FFEC10615FD3"><relationalOp displayName="&lt;= 4 years Starts Before Start Of" operatorType="Less Than or Equal To" quantity="4" type="SBS" unit="years"><elementRef displayName="Triglycerides : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bc5bc8" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></subTree><subTree displayName="RCA Framingham result less than 10 during MP" qdmVariable="false" uuid="149AE3BC-E594-42A6-B9DA-2A469D07ED0A"><relationalOp displayName="During" type="DURING"><elementRef displayName="Framingham coronary heart disease 10 year risk : Risk Category Assessment" id="40280381-3e93-d1af-013e-b297a0bc5bd1" type="qdm"><attribute attrUUID="3204a4f2-fb19-495f-81c0-aa48f9822e04" comparisonValue="10" mode="Less Than" name="result" unit="%"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></subTree><subTree displayName="Count equals 0 of FraminghamCADRiskFactors" qdmVariable="false" uuid="7F1AC5E3-440C-4033-A0B5-66BDB46AC086"><functionalOp displayName="COUNT = 0 " operatorType="Equal To" quantity="0" type="COUNT"><subTreeRef displayName="FraminghamCADRiskFactors" id="48DDF399-6821-4759-A46C-1B9BC89B6B81" type="subTree"/></functionalOp></subTree><subTree displayName="RecentHighHDLResult" qdmVariable="true" uuid="3A382B09-74EF-4CE6-BE31-892288DFB63B"><functionalOp displayName="SATISFIES ALL" type="SATISFIES ALL"><elementRef displayName="High Density Lipoprotein (HDL) : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bc5bc7" type="qdm"/><functionalOp displayName="MOST RECENT" type="MOST RECENT"><relationalOp displayName="During" type="DURING"><elementRef displayName="High Density Lipoprotein (HDL) : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bc5bc7" type="qdm"><attribute attrUUID="a30aed7b-43e8-4eb4-b680-1ed3b24f0d16" mode="Check if Present" name="result"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></functionalOp><elementRef displayName="High Density Lipoprotein (HDL) : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bc5bc7" type="qdm"><attribute attrUUID="f083603c-5401-449e-aa0b-dcca34e3f1b0" comparisonValue="60" mode="Greater Than Or Equal To" name="result" unit="mg/dL"/></elementRef></functionalOp></subTree><subTree displayName="Age less than 55 years at MP" qdmVariable="false" uuid="8B897705-EA03-41DA-9C93-0E5FBBF81769"><functionalOp displayName="Age &lt; 55 years at" operatorType="Less Than" quantity="55" type="AGE AT" unit="years"><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></functionalOp></subTree><subTree displayName="Age less than 45 years at MP" qdmVariable="false" uuid="44EB6580-E2CE-4506-B075-451A06AEC168"><functionalOp displayName="Age &lt; 45 years at" operatorType="Less Than" quantity="45" type="AGE AT" unit="years"><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></functionalOp></subTree><subTree displayName="Count equal 1 FraminghamCADRiskFactors" qdmVariable="false" uuid="E2BA1713-F527-4919-9335-E58AB05DBBA9"><functionalOp displayName="COUNT = 1 " operatorType="Equal To" quantity="1" type="COUNT"><subTreeRef displayName="FraminghamCADRiskFactors" id="48DDF399-6821-4759-A46C-1B9BC89B6B81" type="subTree"/></functionalOp></subTree><subTree displayName="Lab Test Perf LDL Code sat all Most Recent result 4 yr SBE MP less than 160" qdmVariable="false" uuid="720BB8EB-9EBF-4E95-87E2-F2F674678402"><functionalOp displayName="SATISFIES ALL" type="SATISFIES ALL"><elementRef displayName="LDL Code : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bb5bba" type="qdm"/><functionalOp displayName="MOST RECENT" type="MOST RECENT"><relationalOp displayName="&lt;= 4 years Starts Before End Of" operatorType="Less Than or Equal To" quantity="4" type="SBE" unit="years"><elementRef displayName="LDL Code : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bb5bba" type="qdm"><attribute attrUUID="765ff283-3544-4ec7-b3d5-4cc7edcf5208" mode="Check if Present" name="result"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></functionalOp><elementRef displayName="LDL Code : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bb5bba" type="qdm"><attribute attrUUID="3029c9c2-c070-4188-8ac2-783b4dd966ae" comparisonValue="160" mode="Less Than" name="result" unit="mg/dL"/></elementRef></functionalOp></subTree><subTree displayName="CHDandCHDRiskIndicators" qdmVariable="true" uuid="71258BC1-4312-42AD-A50A-447F4643E384"><relationalOp displayName="Starts Before End Of" type="SBE"><setOp displayName="UNION" type="union"><elementRef displayName="Acute Myocardial Infarction : Diagnosis, Active" id="6ae49172-2a88-4449-bdc6-4898f6af5791" type="qdm"/><elementRef displayName="Hemorrhagic Stroke : Diagnosis, Active" id="ae556397-351e-4d2e-8437-619d917d21a1" type="qdm"/><elementRef displayName="Ischemic Stroke : Diagnosis, Active" id="339d8300-7668-4b74-ac06-3d978f21c349" type="qdm"/><elementRef displayName="Ischemic Vascular Disease : Diagnosis, Active" id="04db4edd-444e-47d2-814a-0ec7af58492a" type="qdm"/><elementRef displayName="Coronary Artery Disease No MI : Diagnosis, Active" id="6543a8b3-4a99-4a17-9f87-9ff6a8f03f6e" type="qdm"/><elementRef displayName="Diabetes : Diagnosis, Active" id="7b5727cf-578b-4995-9b35-02e07a676d0a" type="qdm"/><elementRef displayName="Abdominal Aortic Aneurysm : Diagnosis, Active" id="ef041adb-e0ba-4282-9709-5a5d154bbc49" type="qdm"/><elementRef displayName="Peripheral Arterial or Vascular Disease : Diagnosis, Active" id="4e8672a5-058c-44f9-8eeb-81c345e45cd2" type="qdm"/><elementRef displayName="PCI : Procedure, Performed" id="815f86f7-fac9-44bd-95e0-b48ca84eb3f7" type="qdm"/><elementRef displayName="CABG Surgeries : Procedure, Performed" id="0b8538a3-fe5e-4c82-819a-0a3aff0fdc9c" type="qdm"/><elementRef displayName="Carotid Intervention : Procedure, Performed" id="25b9876a-6687-437f-85b4-4adfa0c0f18a" type="qdm"/></setOp><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></subTree><subTree displayName="PalliativeCareorPregnancyExclusion" qdmVariable="true" uuid="82146235-E8FD-4996-9D16-FB423DDEA672"><setOp displayName="UNION" type="union"><relationalOp displayName="During" type="DURING"><elementRef displayName="Palliative Care : Procedure, Order" id="40280381-3e93-d1af-013e-b297a0bb5bbb" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp><relationalOp displayName="Overlaps" type="Overlap"><elementRef displayName="Pregnancy Dx : Diagnosis, Active" id="cb4fe1dc-6da8-4bdb-807a-253a09fce9a5" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" type="qdm"/></relationalOp></setOp></subTree></subTreeLookUp><measureGrouping><group sequence="1"><clause displayName="Initial Population 1" type="initialPopulation" uuid="16825725-1DFE-4A86-9298-444AD93A9C01"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Age greater than or equal to 20 years at MP" id="54385F6D-6CE1-4F22-93EE-E4E9DA49BAE7" type="subTree"/><subTreeRef displayName="Age less than 79 years at MP" id="001EB302-CDD4-4356-B358-A1C511E17A00" type="subTree"/><subTreeRef displayName="Enc Perf Cholesterol Measure Encounter Codes during MP" id="BB766D21-AC99-4E25-A2C1-F5F085BE1312" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></clause><clause displayName="Denominator 1" type="denominator" uuid="746CC758-A6A6-4277-8D7A-95924069B366"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><subTreeRef displayName="Lab Test Perf LDL Code during MP" id="26AA211E-9029-4A14-9C32-E0A46836FD74" type="subTree"/><logicalOp displayName="AND" type="and"><subTreeRef displayName="Lab Test Perf Total Cholesterol during MP" id="7FD31CD6-86B2-44C6-A912-9CC8E72CD376" type="subTree"/><subTreeRef displayName="Lab Test Perf HDL during MP" id="D65C20DE-E60A-4A83-ADC1-ABE0230F62A6" type="subTree"/><subTreeRef displayName="Lab Test Perf Triglycerides during MP" id="0522A896-80D2-4CF5-9F12-A2DFC5AE324A" type="subTree"/></logicalOp></logicalOp><logicalOp displayName="OR" type="or"><subTreeRef displayName="CHDandCHDRiskIndicators" id="71258BC1-4312-42AD-A50A-447F4643E384" type="subTree"/><subTreeRef displayName="RCA Framingham result greater than 20 during MP" id="C5FC1EDC-627A-4D0C-97D6-550EFE31C351" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></logicalOp></clause><clause displayName="Denominator Exclusions 1" type="denominatorExclusions" uuid="CC7CBD6C-1C66-48FE-B02D-9711E5E4C889"><logicalOp displayName="OR" type="or"><subTreeRef displayName="PalliativeCareorPregnancyExclusion" id="82146235-E8FD-4996-9D16-FB423DDEA672" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></clause><clause displayName="Numerator 1" type="numerator" uuid="B2F474D2-0CE9-474B-848D-5C81E3337CEE"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Lab Test Perf LDL Code sat all Most Recent result during MP less than 100" id="9BABA815-7F07-445E-8E7C-4DBE4E4E0839" type="subTree"/></logicalOp></clause><clause displayName="numeratorExclusions" type="numeratorExclusions" uuid="be70a012-c7ea-4ec3-ac35-515acdaa7f3c"><logicalOp displayName="AND" type="and"/></clause><clause displayName="denominatorExceptions" type="denominatorExceptions" uuid="b51ad4f1-7c57-401a-b83e-c64ae943df22"><logicalOp displayName="AND" type="and"/></clause><clause displayName="stratum" type="stratum" uuid="c58ff13d-3938-45b9-9f7a-11aa8b37ccb5"/></group><group sequence="2"><clause displayName="Initial Population 1" type="initialPopulation" uuid="A57A6949-7FD9-447B-B3AB-85DD11F27A42"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Age greater than or equal to 20 years at MP" id="54385F6D-6CE1-4F22-93EE-E4E9DA49BAE7" type="subTree"/><subTreeRef displayName="Age less than 79 years at MP" id="001EB302-CDD4-4356-B358-A1C511E17A00" type="subTree"/><subTreeRef displayName="Enc Perf Cholesterol Measure Encounter Codes during MP" id="BB766D21-AC99-4E25-A2C1-F5F085BE1312" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></clause><clause displayName="Denominator 2" type="denominator" uuid="23670265-2587-429C-BAC5-778E2A48A6D2"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><subTreeRef displayName="Lab Test Perf LDL Code during MP" id="26AA211E-9029-4A14-9C32-E0A46836FD74" type="subTree"/><logicalOp displayName="AND" type="and"><subTreeRef displayName="Lab Test Perf Total Cholesterol during MP" id="7FD31CD6-86B2-44C6-A912-9CC8E72CD376" type="subTree"/><subTreeRef displayName="Lab Test Perf HDL during MP" id="D65C20DE-E60A-4A83-ADC1-ABE0230F62A6" type="subTree"/><subTreeRef displayName="Lab Test Perf Triglycerides during MP" id="0522A896-80D2-4CF5-9F12-A2DFC5AE324A" type="subTree"/></logicalOp></logicalOp><logicalOp displayName="OR" type="or"><subTreeRef displayName="RCA Framingham result greater than equal to 10 during MP" id="D4DFB31C-92D8-47AA-B0EA-433614B01DC6" type="subTree"/><subTreeRef displayName="Count greater than equal to 3 of FraminghamCADRiskFactor" id="B7F7DAFA-23BC-4A06-83FF-BC5FA4D0FE4A" type="subTree"/><logicalOp displayName="AND" type="and"><subTreeRef displayName="Count equal 1 FraminghamCADRiskFactors" id="E2BA1713-F527-4919-9335-E58AB05DBBA9" type="subTree"/><logicalOp displayName="OR" type="or"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Patient Characteristic Sex Male" id="269A842B-9ECE-4B77-A746-8064D5647515" type="subTree"/><subTreeRef displayName="Age greater than or equal to 45 years at MP" id="11CE2948-A957-4027-BCA0-B934B2E43062" type="subTree"/></logicalOp><logicalOp displayName="AND" type="and"><subTreeRef displayName="Patient Characteristic Sex Female" id="6AB9E19A-F545-43F1-B9E0-54F6E718F201" type="subTree"/><subTreeRef displayName="Age greater than or equal to 55 years at MP" id="00D2035B-1BCE-4428-BFDE-06CA2220D93F" type="subTree"/></logicalOp></logicalOp><logicalOp displayName="OR" type="or"><subTreeRef displayName="RecentLowHDLResult" id="9C8B66CF-FD45-46BA-BA34-FF2F3CB85B77" type="subTree"/><logicalOp displayName="OR NOT" type="orNot"><subTreeRef displayName="Lab Test Perf HDL during MP" id="D65C20DE-E60A-4A83-ADC1-ABE0230F62A6" type="subTree"/></logicalOp></logicalOp></logicalOp><logicalOp displayName="AND" type="and"><comment displayName="comment" type="comment"/><subTreeRef displayName="Count equals 2 of FraminghamCADRiskFactors" id="357F3F24-9D2A-4467-8D49-674E78FA87CC" type="subTree"/><logicalOp displayName="OR" type="or"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Patient Characteristic Sex Male" id="269A842B-9ECE-4B77-A746-8064D5647515" type="subTree"/><subTreeRef displayName="Age greater than or equal to 45 years at MP" id="11CE2948-A957-4027-BCA0-B934B2E43062" type="subTree"/></logicalOp><logicalOp displayName="AND" type="and"><subTreeRef displayName="Patient Characteristic Sex Female" id="6AB9E19A-F545-43F1-B9E0-54F6E718F201" type="subTree"/><subTreeRef displayName="Age greater than or equal to 55 years at MP" id="00D2035B-1BCE-4428-BFDE-06CA2220D93F" type="subTree"/></logicalOp></logicalOp></logicalOp><logicalOp displayName="AND" type="and"><subTreeRef displayName="Count equals 2 of FraminghamCADRiskFactors" id="357F3F24-9D2A-4467-8D49-674E78FA87CC" type="subTree"/><logicalOp displayName="OR" type="or"><logicalOp displayName="OR NOT" type="orNot"><comment displayName="comment" type="comment"/><subTreeRef displayName="Lab Test Perf HDL during MP" id="D65C20DE-E60A-4A83-ADC1-ABE0230F62A6" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp><subTreeRef displayName="RecentLowHDLResult" id="9C8B66CF-FD45-46BA-BA34-FF2F3CB85B77" type="subTree"/></logicalOp></logicalOp></logicalOp><logicalOp displayName="AND NOT" type="andNot"><subTreeRef displayName="CHDandCHDRiskIndicators" id="71258BC1-4312-42AD-A50A-447F4643E384" type="subTree"/><subTreeRef displayName="RCA Framingham result greater than 20 during MP" id="C5FC1EDC-627A-4D0C-97D6-550EFE31C351" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></logicalOp></clause><clause displayName="Denominator Exclusions 1" type="denominatorExclusions" uuid="827D1505-8FB6-4F5F-899C-18768C1701D1"><logicalOp displayName="OR" type="or"><subTreeRef displayName="PalliativeCareorPregnancyExclusion" id="82146235-E8FD-4996-9D16-FB423DDEA672" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></clause><clause displayName="Numerator 2" type="numerator" uuid="3A094CBF-5AB9-47BD-AED2-F9A905BE7706"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Lab Test Perf LDL Code sat all Most Recent result during MP less than 130" id="2558E5BD-A977-43FF-A106-2B3F30C45CBC" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></clause><clause displayName="numeratorExclusions" type="numeratorExclusions" uuid="a2cd398c-92eb-495b-a61d-96ba73cdcf2a"><logicalOp displayName="AND" type="and"/></clause><clause displayName="denominatorExceptions" type="denominatorExceptions" uuid="28371d41-4793-4048-8a62-978a92db2d92"><logicalOp displayName="AND" type="and"/></clause><clause displayName="stratum" type="stratum" uuid="90496952-0901-4d90-8260-70b8ce4e64e0"/></group><group sequence="3"><clause displayName="Initial Population 1" type="initialPopulation" uuid="F3C047D3-527F-4398-886F-A6A29867AF01"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Age greater than or equal to 20 years at MP" id="54385F6D-6CE1-4F22-93EE-E4E9DA49BAE7" type="subTree"/><subTreeRef displayName="Age less than 79 years at MP" id="001EB302-CDD4-4356-B358-A1C511E17A00" type="subTree"/><subTreeRef displayName="Enc Perf Cholesterol Measure Encounter Codes during MP" id="BB766D21-AC99-4E25-A2C1-F5F085BE1312" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></clause><clause displayName="Denominator 3" type="denominator" uuid="D9D2745D-0D79-40CA-BC9F-CCC09C84A34D"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><subTreeRef displayName="Lab Test Perf LDL Code during MP" id="26AA211E-9029-4A14-9C32-E0A46836FD74" type="subTree"/><logicalOp displayName="AND" type="and"><subTreeRef displayName="Lab Test Perf Total Cholesterol during MP" id="7FD31CD6-86B2-44C6-A912-9CC8E72CD376" type="subTree"/><subTreeRef displayName="Lab Test Perf HDL during MP" id="D65C20DE-E60A-4A83-ADC1-ABE0230F62A6" type="subTree"/><subTreeRef displayName="Lab Test Perf Triglycerides during MP" id="0522A896-80D2-4CF5-9F12-A2DFC5AE324A" type="subTree"/></logicalOp><subTreeRef displayName="Lab Test Perf LDL Code less than equal to 4 years SBS MP" id="E0807EEB-063D-4CC9-A4C2-792318E60CBF" type="subTree"/><logicalOp displayName="AND" type="and"><subTreeRef displayName="Lab Test Perf Total Cholesterol less than or equal to 4 years SBS MP" id="E6057D37-E12B-4C23-A121-E8889FBCDBA4" type="subTree"/><subTreeRef displayName="Lab Test Perf HDL less than or equal to 4 years SBS MP" id="AF55C607-47BA-4A86-A13C-9F87B23DF3A2" type="subTree"/><subTreeRef displayName="Lab Test Perf Triglycerides less than or equal to 4 years SBS MP" id="90BD9BC5-F79D-47BB-9183-FFEC10615FD3" type="subTree"/></logicalOp></logicalOp><logicalOp displayName="OR" type="or"><subTreeRef displayName="RCA Framingham result less than 10 during MP" id="149AE3BC-E594-42A6-B9DA-2A469D07ED0A" type="subTree"/><subTreeRef displayName="Count equals 0 of FraminghamCADRiskFactors" id="7F1AC5E3-440C-4033-A0B5-66BDB46AC086" type="subTree"/><logicalOp displayName="AND" type="and"><subTreeRef displayName="Count equal 1 FraminghamCADRiskFactors" id="E2BA1713-F527-4919-9335-E58AB05DBBA9" type="subTree"/><subTreeRef displayName="RecentHighHDLResult" id="3A382B09-74EF-4CE6-BE31-892288DFB63B" type="subTree"/><logicalOp displayName="OR" type="or"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Patient Characteristic Sex Male" id="269A842B-9ECE-4B77-A746-8064D5647515" type="subTree"/><subTreeRef displayName="Age greater than or equal to 45 years at MP" id="11CE2948-A957-4027-BCA0-B934B2E43062" type="subTree"/></logicalOp><logicalOp displayName="AND" type="and"><subTreeRef displayName="Patient Characteristic Sex Female" id="6AB9E19A-F545-43F1-B9E0-54F6E718F201" type="subTree"/><subTreeRef displayName="Age greater than or equal to 55 years at MP" id="00D2035B-1BCE-4428-BFDE-06CA2220D93F" type="subTree"/></logicalOp></logicalOp></logicalOp><logicalOp displayName="AND" type="and"><subTreeRef displayName="Count equals 2 of FraminghamCADRiskFactors" id="357F3F24-9D2A-4467-8D49-674E78FA87CC" type="subTree"/><subTreeRef displayName="RecentHighHDLResult" id="3A382B09-74EF-4CE6-BE31-892288DFB63B" type="subTree"/><logicalOp displayName="OR" type="or"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Patient Characteristic Sex Female" id="6AB9E19A-F545-43F1-B9E0-54F6E718F201" type="subTree"/><subTreeRef displayName="Age less than 55 years at MP" id="8B897705-EA03-41DA-9C93-0E5FBBF81769" type="subTree"/></logicalOp><logicalOp displayName="AND" type="and"><subTreeRef displayName="Patient Characteristic Sex Male" id="269A842B-9ECE-4B77-A746-8064D5647515" type="subTree"/><subTreeRef displayName="Age less than 45 years at MP" id="44EB6580-E2CE-4506-B075-451A06AEC168" type="subTree"/></logicalOp></logicalOp></logicalOp><logicalOp displayName="AND" type="and"><subTreeRef displayName="Count equal 1 FraminghamCADRiskFactors" id="E2BA1713-F527-4919-9335-E58AB05DBBA9" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef><logicalOp displayName="OR" type="or"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Patient Characteristic Sex Female" id="6AB9E19A-F545-43F1-B9E0-54F6E718F201" type="subTree"/><subTreeRef displayName="Age less than 55 years at MP" id="8B897705-EA03-41DA-9C93-0E5FBBF81769" type="subTree"/></logicalOp><logicalOp displayName="AND" type="and"><subTreeRef displayName="Patient Characteristic Sex Male" id="269A842B-9ECE-4B77-A746-8064D5647515" type="subTree"/><subTreeRef displayName="Age less than 45 years at MP" id="44EB6580-E2CE-4506-B075-451A06AEC168" type="subTree"/></logicalOp></logicalOp></logicalOp></logicalOp><logicalOp displayName="AND NOT" type="andNot"><subTreeRef displayName="CHDandCHDRiskIndicators" id="71258BC1-4312-42AD-A50A-447F4643E384" type="subTree"/></logicalOp><logicalOp displayName="AND NOT" type="andNot"><subTreeRef displayName="RCA Framingham result greater than equal to 10 during MP" id="D4DFB31C-92D8-47AA-B0EA-433614B01DC6" type="subTree"/></logicalOp></logicalOp></clause><clause displayName="Denominator Exclusions 1" type="denominatorExclusions" uuid="59E701C4-9D89-40BD-8CAA-4CA6ED454D38"><logicalOp displayName="OR" type="or"><subTreeRef displayName="PalliativeCareorPregnancyExclusion" id="82146235-E8FD-4996-9D16-FB423DDEA672" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></clause><clause displayName="Numerator 3" type="numerator" uuid="D93CCB4A-C42A-4197-80D0-3FCC3A46CB2A"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Lab Test Perf LDL Code sat all Most Recent result 4 yr SBE MP less than 160" id="720BB8EB-9EBF-4E95-87E2-F2F674678402" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></clause><clause displayName="numeratorExclusions" type="numeratorExclusions" uuid="f29e78aa-fb8c-4c5a-920e-2f1b3902015e"><logicalOp displayName="AND" type="and"/></clause><clause displayName="denominatorExceptions" type="denominatorExceptions" uuid="82ffaff4-6c4a-46dd-bc9a-e40f3294f77b"><logicalOp displayName="AND" type="and"/></clause><clause displayName="stratum" type="stratum" uuid="bcdc2ceb-ce24-4176-85ab-c05a846d7071"/></group></measureGrouping><elementLookUp><qdm datatype="Diagnosis, Active" id="ef041adb-e0ba-4282-9709-5a5d154bbc49" name="Abdominal Aortic Aneurysm" oid="2.16.840.1.113762.1.4.1047.17" suppDataElement="false" taxonomy="Grouping" uuid="ef041adb-e0ba-4282-9709-5a5d154bbc49" version="1.0"/><qdm datatype="Diagnosis, Active" id="6ae49172-2a88-4449-bdc6-4898f6af5791" name="Acute Myocardial Infarction" oid="2.16.840.1.113883.3.464.1003.104.12.1001" suppDataElement="false" taxonomy="Grouping" uuid="6ae49172-2a88-4449-bdc6-4898f6af5791" version="1.0"/><qdm codeSystemName="Quality Insights of Pennsylvania" datatype="Medication, Active" id="40280381-3e93-d1af-013e-b297a0bc5bd8" name="Anti-Hypertensive Pharmacologic Therapy" oid="2.16.840.1.113883.3.600.1476" suppDataElement="false" taxonomy="RXNORM" uuid="40280381-3e93-d1af-013e-b297a0bc5bd8" version="1"/><qdm datatype="Patient Characteristic Birthdate" id="4a69b659-903d-493e-a7fb-f7db4b5daf5f" name="Birthdate" oid="21112-8" suppDataElement="false" taxonomy="SNOMED-CT" uuid="4a69b659-903d-493e-a7fb-f7db4b5daf5f" version="1.0"/><qdm datatype="Procedure, Performed" id="0b8538a3-fe5e-4c82-819a-0a3aff0fdc9c" name="CABG Surgeries" oid="2.16.840.1.113883.3.666.5.694" suppDataElement="false" taxonomy="Grouping" uuid="0b8538a3-fe5e-4c82-819a-0a3aff0fdc9c" version="1.0"/><qdm datatype="Procedure, Performed" id="25b9876a-6687-437f-85b4-4adfa0c0f18a" name="Carotid Intervention" oid="2.16.840.1.113883.3.117.1.7.1.204" suppDataElement="false" taxonomy="Grouping" uuid="25b9876a-6687-437f-85b4-4adfa0c0f18a" version="1.0"/><qdm codeSystemName="Centers for Medicare &amp; Medicaid Services" datatype="Encounter, Performed" id="40280381-3e93-d1af-013e-b297a0bd5bdf" name="Cholesterol Measure Encounter Codes" oid="2.16.840.1.113883.3.600.1951" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-b297a0bd5bdf" version="1"/><qdm datatype="Diagnosis, Active" id="6543a8b3-4a99-4a17-9f87-9ff6a8f03f6e" name="Coronary Artery Disease No MI" oid="2.16.840.1.113883.3.526.3.369" suppDataElement="false" taxonomy="Grouping" uuid="6543a8b3-4a99-4a17-9f87-9ff6a8f03f6e" version="1.0"/><qdm codeSystemName="Quality Insights of Pennsylvania" datatype="Patient Characteristic" id="40280381-3e93-d1af-013e-b297a0bb5bb6" name="Current Tobacco Smoker" oid="2.16.840.1.113883.3.600.2390" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3e93-d1af-013e-b297a0bb5bb6" version="1"/><qdm datatype="Diagnosis, Active" id="7b5727cf-578b-4995-9b35-02e07a676d0a" name="Diabetes" oid="2.16.840.1.113883.3.464.1003.103.12.1001" suppDataElement="false" taxonomy="Grouping" uuid="7b5727cf-578b-4995-9b35-02e07a676d0a" version="1.0"/><qdm codeSystemName="Quality Insights of Pennsylvania" datatype="Diagnosis, Active" id="40280381-3e93-d1af-013e-b297a0bc5bcf" name="Diagnosis of hypertension " oid="2.16.840.1.113883.3.600.263" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-b297a0bc5bcf" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Ethnicity" id="40280381-3e93-d1af-013e-b297a0bb5bbe" name="Ethnicity" oid="2.16.840.1.114222.4.11.837" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3e93-d1af-013e-b297a0bb5bbe" version="1"/><qdm datatype="Patient Characteristic Expired" id="f39f5cfd-0160-4180-954f-04fb3836cc23" name="Expired" oid="419099009" suppDataElement="false" taxonomy="SNOMED-CT" uuid="f39f5cfd-0160-4180-954f-04fb3836cc23" version="1.0"/><qdm codeSystemName="Centers for Medicare &amp; Medicaid Services" datatype="Diagnosis, Family History" id="40280381-3e93-d1af-013e-b297a0bc5bce" name="Family History CHD" oid="2.16.840.1.113883.3.600.1557" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3e93-d1af-013e-b297a0bc5bce" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Patient Characteristic Sex" id="40280381-3e93-d1af-013e-b297a0bd5be7" name="Female" oid="2.16.840.1.113883.3.560.100.2" suppDataElement="false" taxonomy="AdministrativeSex" uuid="40280381-3e93-d1af-013e-b297a0bd5be7" version="1"/><qdm codeSystemName="Centers for Medicare &amp; Medicaid Services" datatype="Risk Category Assessment" id="40280381-3e93-d1af-013e-b297a0bc5bd1" name="Framingham coronary heart disease 10 year risk" oid="2.16.840.1.113883.3.600.1561" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-b297a0bc5bd1" version="1"/><qdm datatype="Diagnosis, Active" id="ae556397-351e-4d2e-8437-619d917d21a1" name="Hemorrhagic Stroke" oid="2.16.840.1.113883.3.117.1.7.1.212" suppDataElement="false" taxonomy="Grouping" uuid="ae556397-351e-4d2e-8437-619d917d21a1" version="1.0"/><qdm codeSystemName="Quality Insights of Pennsylvania" datatype="Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bc5bc7" name="High Density Lipoprotein (HDL)" oid="2.16.840.1.113883.3.600.875" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-b297a0bc5bc7" version="1"/><qdm datatype="Diagnosis, Active" id="339d8300-7668-4b74-ac06-3d978f21c349" name="Ischemic Stroke" oid="2.16.840.1.113883.3.117.1.7.1.247" suppDataElement="false" taxonomy="Grouping" uuid="339d8300-7668-4b74-ac06-3d978f21c349" version="1.0"/><qdm datatype="Diagnosis, Active" id="04db4edd-444e-47d2-814a-0ec7af58492a" name="Ischemic Vascular Disease" oid="2.16.840.1.113883.3.464.1003.104.12.1003" suppDataElement="false" taxonomy="Grouping" uuid="04db4edd-444e-47d2-814a-0ec7af58492a" version="1.0"/><qdm codeSystemName="Quality Insights of Pennsylvania" datatype="Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bb5bba" name="LDL Code" oid="2.16.840.1.113883.3.600.872" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-b297a0bb5bba" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Patient Characteristic Sex" id="40280381-3e93-d1af-013e-b297a0bd5be8" name="Male" oid="2.16.840.1.113883.3.560.100.1" suppDataElement="false" taxonomy="AdministrativeSex" uuid="40280381-3e93-d1af-013e-b297a0bd5be8" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Timing Element" id="40280381-3e93-d1af-013e-b297a0bb5bc3" name="Measurement Period" oid="2.16.840.1.113883.3.67.1.101.1.53" suppDataElement="false" taxonomy="NQF" uuid="40280381-3e93-d1af-013e-b297a0bb5bc3" version="1"/><qdm codeSystemName="National Library of Medicine" datatype="Patient Characteristic Sex" id="40280381-3e93-d1af-013e-b297a0bb5bbc" name="ONC Administrative Sex" oid="2.16.840.1.113762.1.4.1" suppDataElement="true" taxonomy="AdministrativeGender" uuid="40280381-3e93-d1af-013e-b297a0bb5bbc" version="1"/><qdm codeSystemName="Quality Insights of Pennslyvania" datatype="Procedure, Order" id="40280381-3e93-d1af-013e-b297a0bb5bbb" name="Palliative Care" oid="2.16.840.1.113883.3.600.1.1579" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-b297a0bb5bbb" version="1"/><qdm codeSystemName="PHDSC" datatype="Patient Characteristic Payer" id="40280381-3e93-d1af-013e-b297a0bb5bbf" name="Payer" oid="2.16.840.1.114222.4.11.3591" suppDataElement="true" taxonomy="SOP" uuid="40280381-3e93-d1af-013e-b297a0bb5bbf" version="1"/><qdm datatype="Procedure, Performed" id="815f86f7-fac9-44bd-95e0-b48ca84eb3f7" name="PCI" oid="2.16.840.1.113762.1.4.1045.67" suppDataElement="false" taxonomy="Grouping" uuid="815f86f7-fac9-44bd-95e0-b48ca84eb3f7" version="1.0"/><qdm datatype="Diagnosis, Active" id="4e8672a5-058c-44f9-8eeb-81c345e45cd2" name="Peripheral Arterial or Vascular Disease" oid="2.16.840.1.113762.1.4.1047.21" suppDataElement="false" taxonomy="Grouping" uuid="4e8672a5-058c-44f9-8eeb-81c345e45cd2" version="1.0"/><qdm datatype="Diagnosis, Active" id="cb4fe1dc-6da8-4bdb-807a-253a09fce9a5" name="Pregnancy Dx" oid="2.16.840.1.113883.3.600.1.1623" suppDataElement="false" taxonomy="Grouping" uuid="cb4fe1dc-6da8-4bdb-807a-253a09fce9a5" version="1.0"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Race" id="40280381-3e93-d1af-013e-b297a0bb5bbd" name="Race" oid="2.16.840.1.114222.4.11.836" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3e93-d1af-013e-b297a0bb5bbd" version="1"/><qdm codeSystemName="Quality Insights of Pennsylvania" datatype="Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bb5bc6" name="Total Cholesterol" oid="2.16.840.1.113883.3.600.879" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-b297a0bb5bc6" version="1"/><qdm codeSystemName="Quality Insights of Pennsylvania" datatype="Laboratory Test, Performed" id="40280381-3e93-d1af-013e-b297a0bc5bc8" name="Triglycerides" oid="2.16.840.1.113883.3.600.883" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-b297a0bc5bc8" version="1"/></elementLookUp></measure>